Skip to main content
Premium Trial:

Request an Annual Quote

Found in Colorado

The first case of the SARS-CoV-2 strain that is suspected to be more infectious has been identified in the US, the New York Times reports.

Earlier this month, heath officials in the UK noticed a new viral strain — called B.1.1.7 — that appeared to spread more easily. A new preprint further suggests that the strain may be 56 percent more transmissible, though, as the Times notes, there is no evidence the strain leads to more severe disease. 

The B.1.1.7 strain had since been detected in Australia, Canada, and South Korea, and now has been found in Colorado, the Washington Post reports. The Times notes that the strain may not have arisen in the UK, but was first detected there as it has a SARS-CoV-2 sequencing program in place. It adds that the earliest B.1.1.7 strain uncovered in the UK was from September, suggesting it likely had already spread between countries. 

As the strain has been found in a Colorado man with no history of travel, it suggests the strain may be well established in the US, the Times adds.

The Post further notes, though, that there is a dearth of viral genome data from the US. "The lack of virus sequencing and case tracking in the USA is a scandal," Jeremy Luban, a virologist at the University of Massachusetts Medical School, tells it.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.